Douglas H. Richie Jr., D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 550 Pacific Coast Hwy, #209, Seal Beach, CA 90740 Phone: 562-493-2451 Fax: 562-596-3157 |
Dr. Marc D Spitz, D.p.m. Inc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1920 Saint Andrews Dr, Seal Beach, CA 90740 Phone: 562-799-0656 Fax: 562-799-0756 |
Atefeh Izadi, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 550 Pacific Coast Hwy, Suite 209, Seal Beach, CA 90740 Phone: 562-493-2451 |
Dr. Douglas Lawrence Mccune, DPM Podiatrist - Primary Podiatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1661 Golden Rain Rd, Seal Beach, CA 90740 Phone: 562-795-6210 Fax: 562-795-6272 |
Dr. Jeremy L Cook, DPM Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 550 Pacific Coast Highway, Suite 209, Seal Beach, CA 90740 Phone: 562-493-2451 Fax: 562-596-3157 |
Marc D Spitz D P M Inc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1920 Saint Andrews Dr, Seal Beach, CA 90740 Phone: 562-799-0656 Fax: 562-799-0756 |
News Archive
A recent study reveals how the non-structural protein 1 (NSP1) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) plays a crucial role in inhibiting the host cell protein synthesis but simultaneously facilitating the viral protein synthesis.
If you are getting forgetful as you get older, then a research team from the University of Reading and the Peninsula Medical School in the South West of England may have good news for you.
Researchers in the Netherlands examined the relation between handedness and incidence of breast cancer in over 12,000 healthy, middle aged women born between 1932 and 1941.
Congress will consider a new drug approval pathway to encourage development of critically needed, lifesaving antibiotics as part of a strategy to address the public health crisis of antibiotic resistance. The Infectious Diseases Society of America (IDSA) proposed the new pathway, the "Special Population Limited Medical Use (SPLMU)" mechanism, to provide an important new approval option for companies interested in developing drugs to treat patients with serious infections where few or no treatment options exist.
› Verified 7 days ago